Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorFERREIRA, A. C.
dc.contributor.authorGOMES-GOUVEA, Michele Soares
dc.contributor.authorLISBOA-NETO, G.
dc.contributor.authorMENDES-CORREA, M. C. J.
dc.contributor.authorPICONE, C. M.
dc.contributor.authorSALLES, N. A.
dc.contributor.authorMENDRONE-JUNIOR, A.
dc.contributor.authorCARRILHO, F. J.
dc.contributor.authorPINHO, J. R. R.
dc.date.accessioned2018-02-02T16:55:04Z
dc.date.available2018-02-02T16:55:04Z
dc.date.issued2018
dc.description.abstractIn Brazil, the circulation of hepatitis E virus (HEV) has been demonstrated in distinct groups of individuals and some animals, but its prevalence among individuals with human immunodeficiency virus (HIV) infection is unknown. This study aimed to assess the frequency of serological and molecular HEV markers in individuals infected with HIV from So Paulo, Brazil. Serum and plasma samples of 354 HIV-infected patients collected between 2007 and 2013 were included. All samples were tested for anti-HEV IgG and IgM antibodies and HEV RNA. Anti-HEV IgG and IgM antibodies were detected in 10.7% (38/354) and 1.4% (5/354) of the samples, respectively. Both antibodies were detected simultaneously in only two samples. HEV RNA was not detected in any sample. There was no significant correlation of anti-HEV serological status (positivity to anti-HEV IgG and/or IgM) with sex, age, CD4(+) T cell count, HIV viral load, antiretroviral therapy, liver enzyme levels, or coinfection with hepatitis B virus and/or hepatitis C virus. Our study provides serological evidence of past and recent HEV infections in HIV-infected patients from So Paulo, Brazil. However, the occurrence of ongoing HEV infection appears be a rare event in this population.
dc.description.indexMEDLINE
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2012/50504-2]
dc.description.sponsorshipAlves de Queiroz Family Fund for Research
dc.description.sponsorshipFAPESP [2012/21588-3]
dc.description.sponsorshipCAPES
dc.description.sponsorshipCNPq (Bolsista de Produtividade em Pesquisa do CNPq - Nivel 2)
dc.identifier.citationARCHIVES OF VIROLOGY, v.163, n.1, p.43-49, 2018
dc.identifier.doi10.1007/s00705-017-3562-3
dc.identifier.eissn1432-8798
dc.identifier.issn0304-8608
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/24918
dc.language.isoeng
dc.publisherSPRINGER WIEN
dc.relation.ispartofArchives of Virology
dc.rightsrestrictedAccess
dc.rights.holderCopyright SPRINGER WIEN
dc.subject.otherhuman-immunodeficiency-virus
dc.subject.otherliver-transplant recipients
dc.subject.othersoutheastern brazil
dc.subject.othere seroprevalence
dc.subject.otherhev infection
dc.subject.otherblood-donors
dc.subject.othernon-a
dc.subject.othernon-b
dc.subject.otherantibodies
dc.subject.otherprevalence
dc.subject.wosVirology
dc.titleSerological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalSALLES, N. A.:Fundacao Prosangue Hemoctr Sao Paulo, Sao Paulo, SP, Brazil
hcfmusp.citation.scopus19
hcfmusp.contributor.author-fmusphcARIANA CAROLINA FERREIRA
hcfmusp.contributor.author-fmusphcMICHELE SOARES GOMES GOUVEA
hcfmusp.contributor.author-fmusphcGASPAR LISBOA NETO
hcfmusp.contributor.author-fmusphcMARIA CASSIA JACINTHO MENDES CORREA
hcfmusp.contributor.author-fmusphcCAMILA DE MELO PICONE
hcfmusp.contributor.author-fmusphcALFREDO MENDRONE JUNIOR
hcfmusp.contributor.author-fmusphcFLAIR JOSE CARRILHO
hcfmusp.contributor.author-fmusphcJOAO RENATO REBELLO PINHO
hcfmusp.description.beginpage43
hcfmusp.description.endpage49
hcfmusp.description.issue1
hcfmusp.description.volume163
hcfmusp.origemWOS
hcfmusp.origem.pubmed28965214
hcfmusp.origem.scopus2-s2.0-85030184624
hcfmusp.origem.wosWOS:000419456300005
hcfmusp.publisher.cityWIEN
hcfmusp.publisher.countryAUSTRIA
hcfmusp.relation.referenceAssis Sandra Breder, 2002, Rev. Soc. Bras. Med. Trop., V35, P155, DOI 10.1590/S0037-86822002000200005
hcfmusp.relation.referenceBALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370
hcfmusp.relation.referenceBalayan MS, 1997, J VIRAL HEPATITIS, V4, P279, DOI 10.1046/j.1365-2893.1997.00050.x
hcfmusp.relation.referenceBortoliero André Luiz, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P87, DOI 10.1590/S0036-46652006000200006
hcfmusp.relation.referenceColson P, 2009, J CLIN VIROL, V45, P269, DOI 10.1016/j.jcv.2009.06.002
hcfmusp.relation.referenceCrum-Cianflone NF, 2012, EMERG INFECT DIS, V18, P502, DOI 10.3201/eid1803.111278
hcfmusp.relation.referenceLana MVD, 2014, TROP ANIM HEALTH PRO, V46, P399, DOI 10.1007/s11250-013-0503-3
hcfmusp.relation.referenceDalton HR, 2016, DIGEST DIS, V34, P308, DOI 10.1159/000444468
hcfmusp.relation.referenceDalton HR, 2014, FUTURE MICROBIOL, V9, P1361, DOI 10.2217/fmb.14.89
hcfmusp.relation.referenceDalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778
hcfmusp.relation.referencede Freitas NR, 2016, MEM I OSWALDO CRUZ, V111, P692, DOI 10.1590/0074-02760160256
hcfmusp.relation.referenceDebes JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160082
hcfmusp.relation.referenceDebes JD, 2016, J CLIN VIROL, V80, P102, DOI 10.1016/j.jcv.2016.05.006
hcfmusp.relation.referencedos Santos DCM, 2002, MEM I OSWALDO CRUZ, V97, P637, DOI 10.1590/S0074-02762002000500007
hcfmusp.relation.referenceFainboim H, 1999, J VIRAL HEPATITIS, V6, P53, DOI 10.1046/j.1365-2893.1999.t01-1-6120135.x
hcfmusp.relation.referenceFeldt T, 2013, J CLIN VIROL, V58, P18, DOI 10.1016/j.jcv.2013.05.004
hcfmusp.relation.referenceGeng YS, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.15618
hcfmusp.relation.referenceGerolami R, 2008, NEW ENGL J MED, V358, P859, DOI 10.1056/NEJMc0708687
hcfmusp.relation.referenceGoncales NSL, 2000, CLIN DIAGN LAB IMMUN, V7, P813, DOI 10.1128/CDLI.7.5.813-816.2000
hcfmusp.relation.referenceGuimaraes FR, 2005, BRAZ J MICROBIOL, V36, P223, DOI 10.1590/S1517-83822005000300004
hcfmusp.relation.referenceHaagsma EB, 2008, LIVER TRANSPLANT, V14, P547, DOI 10.1002/lt.21480
hcfmusp.relation.referenceHARTL J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/V8110299
hcfmusp.relation.referenceHartl J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080211
hcfmusp.relation.referenceHeldt FH, 2016, FOOD ENVIRON VIROL, V8, P200, DOI 10.1007/s12560-016-9243-7
hcfmusp.relation.referenceHering T, 2014, J MED VIROL, V86, P948, DOI 10.1002/jmv.23915
hcfmusp.relation.referenceIngiliz P, 2016, CLIN RES HEPATOL GAS, V40, pE23, DOI 10.1016/j.clinre.2016.01.005
hcfmusp.relation.referenceJothikumar N, 2006, J VIROL METHODS, V131, P65, DOI [10.1016/j.jviromet.2005.07.004, 10.1016/j.viromet.2005.07.004]
hcfmusp.relation.referenceKaba M, 2011, J MED VIROL, V83, P1704, DOI 10.1002/jmv.22177
hcfmusp.relation.referenceKamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992
hcfmusp.relation.referenceKamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13
hcfmusp.relation.referenceKamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7
hcfmusp.relation.referenceKeane FE, 2012, HIV MED, V13, P83, DOI 10.1111/j.1468-1293.2011.00942.x
hcfmusp.relation.referenceKenfak-Foguena A, 2011, EMERG INFECT DIS, V17, P1074, DOI [10.3201/eid1706.101067, 10.3201/eid/1706.101067]
hcfmusp.relation.referenceKhudyakov Y, 2011, VIRUS RES, V161, P84, DOI 10.1016/j.virusres.2011.06.006
hcfmusp.relation.referenceKoning L, 2013, J HEART LUNG TRANSPL, V32, P78, DOI 10.1016/j.healun.2012.10.008
hcfmusp.relation.referenceKuniholm MH, 2016, HEPATOLOGY, V63, P712, DOI 10.1002/hep.28384
hcfmusp.relation.referenceLee GH, 2016, GASTROENTEROLOGY, V150, P355, DOI 10.1053/j.gastro.2015.10.048
hcfmusp.relation.referencedos Santos DRL, 2009, VET J, V182, P474, DOI 10.1016/j.tvjl.2008.08.001
hcfmusp.relation.referenceLyra AC, 2005, BRAZ J MED BIOL RES, V38, P767, DOI 10.1590/S0100-879X2005000500015
hcfmusp.relation.referenceMartins RMB, 2014, J CLIN VIROL, V59, P188, DOI 10.1016/j.jcv.2014.01.002
hcfmusp.relation.referenceMaylin S, 2012, J CLIN VIROL, V53, P346, DOI 10.1016/j.jcv.2012.01.001
hcfmusp.relation.referenceNeukam K, 2013, CLIN INFECT DIS, V57, P465, DOI 10.1093/cid/cit224
hcfmusp.relation.referencePaiva HH, 2007, BRAZ J MICROBIOL, V38, P693, DOI 10.1590/S1517-83822007000400020
hcfmusp.relation.referenceParana R, 1997, AM J TROP MED HYG, V57, P60, DOI 10.4269/ajtmh.1997.57.60
hcfmusp.relation.referencePassos-Castilho AM, 2017, BRAZ J INFECT DIS, V21, P535, DOI 10.1016/j.bjid.2017.05.004
hcfmusp.relation.referencePassos-Castilho AM, 2016, J MED VIROL, V88, P361, DOI 10.1002/jmv.24336
hcfmusp.relation.referencePassos-Castilho AM, 2014, J CLIN MICROBIOL, V52, P4425, DOI 10.1128/JCM.02286-14
hcfmusp.relation.referencePischke S, 2010, LIVER TRANSPLANT, V16, P74, DOI 10.1002/lt.21958
hcfmusp.relation.referencePolitou M, 2015, J MED VIROL, V87, P1517, DOI 10.1002/jmv.24214
hcfmusp.relation.referenceRamezani A, 2013, INT J STD AIDS, V24, P769, DOI 10.1177/0956462413484457
hcfmusp.relation.referenceRivero-Juarez A, 2015, J INFECTION, V70, P680, DOI 10.1016/j.jinf.2014.11.010
hcfmusp.relation.referenceRode OD, 2014, EUR J CLIN MICROBIOL, V33, P2231, DOI 10.1007/s10096-014-2187-7
hcfmusp.relation.referenceScotto G, 2015, INFECT DIS-NOR, V47, P707, DOI 10.3109/23744235.2015.1049658
hcfmusp.relation.referenceSingh GJ, 2011, HIV MED, V12, P44
hcfmusp.relation.referenceSmith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0
hcfmusp.relation.referenceSouto FJD, 1997, AM J TROP MED HYG, V57, P149, DOI 10.4269/ajtmh.1997.57.149
hcfmusp.relation.referencede Souza AJS, 2012, COMP IMMUNOL MICROB, V35, P477, DOI 10.1016/j.cimid.2012.04.004
hcfmusp.relation.referenceTamura A, 2007, HEPATOL RES, V37, P113, DOI 10.1111/j.1872-034X.2007.00024.x
hcfmusp.relation.referenceTrinta KS, 2001, MEM I OSWALDO CRUZ, V96, P25, DOI 10.1590/S0074-02762001000100004
hcfmusp.relation.referenceVitral CL, 2005, MEM I OSWALDO CRUZ, V100, P117, DOI 10.1590/S0074-02762005000200003
hcfmusp.relation.referenceWenzel JJ, 2013, J INFECT DIS, V207, P497, DOI 10.1093/infdis/jis688
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication425a3a7f-2a7f-4d65-b381-4b8a8c868164
relation.isAuthorOfPublication40082688-92fd-4f91-8d9f-44c85088369d
relation.isAuthorOfPublication48d0d981-35ab-463a-aebe-1759c07ded05
relation.isAuthorOfPublication4ec4044d-75d1-4d30-8176-efd04b22c8d6
relation.isAuthorOfPublication0a3c3159-e862-4ccf-9dac-de32cb3cbdd9
relation.isAuthorOfPublication4a7139e3-a8d0-4218-8aeb-fdd2698cbdd0
relation.isAuthorOfPublication9221b8d6-ad80-46e5-a56f-fb3b28a8c155
relation.isAuthorOfPublication0ada2eb1-5ac2-4e40-b4e2-6af14f33268b
relation.isAuthorOfPublication.latestForDiscovery425a3a7f-2a7f-4d65-b381-4b8a8c868164
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_FERREIRA_Serological_and_molecular_markers_of_hepatitis_E_virus_2018.PDF
Tamanho:
537.72 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - LIM/52
Artigos e Materiais de Revistas Científicas - ODS/03